Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_assertion type Assertion NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_head.
- NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_assertion description "[Thus, this new cell line with partial androgen responsiveness and PSA expression can serve as a functionally relevant model system of bone metastatic prostate cancer, and can be used to investigate the role of AR mutations in prostate cancer and its progression to androgen independence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_provenance.
- NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_assertion evidence source_evidence_literature NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_provenance.
- NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_assertion SIO_000772 10569618 NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_provenance.
- NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_assertion wasDerivedFrom befree-2016 NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_provenance.
- NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_assertion wasGeneratedBy ECO_0000203 NP268103.RAEAPfJ0-0GeY1eCI81A9MEBKs05aF-lOvBceGa3Oe9bs130_provenance.